Background
==========

In 1970, Ohno \[[@B1]\] proposed that duplication of individual genes, chromosomal segments or whole genomes plays an important role in genome evolution, provides for increasing organismal complexity and contributes to morphological diversification among vertebrates \[[@B2]-[@B4]\]. The role of gene duplicates in generating morphological and functional diversity has been discussed by various researchers (see \[[@B5]\] and references therein). To our knowledge, Ohno \[[@B1]\] was the first to suggest possible fates for duplicated genes by the process of either nonfunctionalization or neofunctionalization. Nonfunctionalization of a duplicated gene occurs due to deleterious mutations accumulating in the protein coding region, leading to gene silencing and subsequent loss of one of the duplicate genes from the genome. Ohno \[[@B1]\] further argued that nonfunctionalization is the common fate of a duplicated gene. Neofunctionalization results from mutations in the protein coding region that gives rise to a novel function for a gene product. If this novel function benefits the organism, the gene will be retained in the genome. With complete genomic DNA sequences becoming increasingly available, it is apparent that a greater proportion of gene duplicates are preserved in genomes than that predicted by Ohno's model \[[@B6]\]. In light of these observations, Force *et al.*\[[@B6]\], subsequently elaborated by Lynch and Conery \[[@B7]\], proposed the duplication-degeneration-complementation (DDC) model. In the DDC model, subfunctionalization is the process by which the functions of the ancestral gene are subdivided between the duplicated genes. Subfunctionalization in the DDC model was proposed as an alternative mechanism to Ohno's neofunctionalization \[[@B1]\] to explain the high retention rate of duplicated genes in the genome. Force *et al.*\[[@B6]\], however, did not exclude neofunctionalization, in which one of the duplicated genes acquires a novel function. In the DDC model, subfunctionalization and neofunctionalization occur by either loss or gain of *cis*-regulatory elements in the promoters of the duplicated genes.

Fatty acid-binding protein *(FABP)* genes belong to the multigene family of intracellular lipid-binding protein (*iLBP*) genes that also includes the cellular retinol-binding protein (*CRBP*) and the cellular retinoic acid-binding protein (*CRABP*) genes \[[@B8]-[@B12]\]. To date, eighteen paralogous *iLBP* genes, including 12 *FABPs*, 4 *CRBPs* and 2 *CRABPs* have been identified in the animal kingdom. No *FABP* genes have been found in plants or fungi, leading Schaap *et al.*\[[@B9]\] to suggest that the first *FABP* gene emerged after the divergence of animals from plants, some 930--1000 million years ago (mya). About 230--400 mya, the *iLBP* multigene family was further augmented in teleost fishes by a whole genome duplication (WGD) event early in teleost fish lineage \[[@B4],[@B13]-[@B17]\]. Based on complementary DNA (cDNA) sequence, gene structure, conserved gene synteny with their mammalian, avian and fish orthologs, and spatio-temporal patterns of expression, we have characterized 12 zebrafish *fabp* genes \[[@B18]-[@B30]\]. Of these 12 zebrafish *fabp* genes, eight (four pairs) *fabp1a/fabp1b, fabp7a/fabp7bfabp10a/fabp10b* and *fabp11a/fabp11b* arose as a result of the teleost fish-specific WGD \[[@B23],[@B25],[@B28],[@B29]\]. One pair of duplicated genes, *fabp1b.1 and fabp1b.2*, is tandemly arrayed on chromosome 8 separated by 3.8 kb of DNA \[[@B30]\]. This duplication, subsequent to the WGD early in the fish lineage, is presumably the result of unequal crossing-over between homologous chromosomes during meiosis. The total number of duplicated genes retained in the zebrafish genome following the WGD event is estimated to be 14-30% \[[@B31],[@B32]\]. Surprisingly, 73% of the duplicated *fabp* genes have been retained in the zebrafish genome. Only three zebrafish *fabp* genes exist as single copies, *fabp2fabp3* and *fabp6*. Originally, FABPs were named according to their initial tissue of isolation. This nomenclature has become increasingly confusing as some tissues contain more than one FABP, and some FABPs are found in many tissues. As such, we have chosen to use in this paper the nomenclature proposed by Hertzel and Bernlohr \[[@B33]\]*e.g.,* FABP1, FABP2, *etc.* Although different *FABP* genes exhibit distinct, but sometimes overlapping, tissue-specific patterns of expression, the tertiary structure of *FABP* genes and their genomic organization are highly conserved \[[@B12],[@B34],[@B35]\]. Almost all *FABP*/*fabp* genes, with the exception of the *FABP3* gene in desert locust \[[@B36]\], the *fabp1a* gene from zebrafish \[[@B25]\] and *fabp11a* gene from medaka \[[@B37]\], consist of four exons of comparable coding capacity separated by three introns of varying sizes between paralogous and orthologous *FABP*/*fabp* genes in different species \[[@B8],[@B9],[@B38]-[@B40]\]. Despite extensive studies on the structure of FABPs, binding properties and *in vitro* lipid transfer mechanisms, their precise physiological role remains elusive. However, several studies \[reviewed in 12\] have implicated FABPs in myriad cellular processes that include: (1) binding and sequestering of long-chain fatty acids, bile salts and other hydrophobic ligands; (2) transport of these ligands to intracellular compartments for metabolism and energy production; (3) interaction with other enzyme systems and transport proteins; and (4) transport of fatty acids (FAs) to the nucleus to regulate gene transcription *via* activation of the nuclear receptors, the peroxisome proliferator-activated receptors (PPARs) (see \[[@B41]\] and references therein). Currently, our knowledge of the regulatory elements controlling the expression of the *FABP* genes is limited and based mainly on studies of mammalian *FABP* genes and one *FABP* gene in desert locust \[[@B42]-[@B46]\]. Her *et al.*\[[@B47],[@B48]\] cloned the 5\' upstream regions, including the basal promoters, of the zebrafish *fabp10a* and *fabp2* genes. They identified a 435 base pairs (bp) region with two distinct liver regulatory elements in the liver-basic fatty acid-binding protein (*fabp10a*) gene, which is sufficient to modulate liver regional expression in transgenic zebrafish \[[@B47]\]. A 192 bp region was identified in the 5\' upstream region of the intestinal-type fatty acid-binding protein (*fabp2*) gene sufficient to direct intestine-specific expression in zebrafish larval development \[[@B48]\]. Neither of these studies provided insight into why both duplicated *fabp10* genes, *fabp10a* and *fabp10b,* were retained in the zebrafish genome, or why a copy of the duplicated *fabp2* gene was lost from the zebrafish genome following the WGD in the teleost fishes.

In previous studies, we have shown that transcriptional initiation of only one copy in each of three sets of duplicated *fabp* genes of zebrafish, *fabp1a/fabp1b.1/fabp1b.2, fabp7a/fabp7b* and *fabp11a/fabp11b*, is modulated by dietary FAs in a given tissue \[[@B49]\]. Since FAs are known to be ligands of PPARs that leads to transcriptional up-regulation of target genes, we anticipated that the transcriptional modulation of *fabp* genes in various tissues of zebrafish fed different FAs might be mediated by PPARs. The goal of the present research was, therefore, to investigate whether the duplicated *fabp* genes in zebrafish are differentially regulated by PPAR, by using clofibrate, a PPAR agonist. Clofibrate has been used extensively to investigate the regulation of gene transcription in vertebrates, owing to its specific binding with PPARα, and to a lesser extent to PPARγ, and its effect on the transcription of specific genes involved in lipid metabolism \[[@B50]-[@B57]\]. We assayed the steady-state levels of *fabp* mRNA and heterogeneous nuclear RNA (hnRNA) transcripts for four sets of duplicated *fabp* genes, *fabp1a/fabp1b.1/fabp1b.2, fabp7a/fabp7b, fabp10a/fabp10b* and *fabp11a/fabp11b* in zebrafish fed different concentrations of clofibrate to determine if clofibrate induced transcriptional initiation of only one of a pair of duplicated *fabp* genes. We show here, however, that clofibrate induced the transcriptional initiation of both pairs of some duplicated *fabp* genes in zebrafish, but the induction is differentially regulated by an, as yet, unknown tissue-specific mechanism(s).

Results and discussion
======================

Zebrafish is responsive to the peroxisome proliferator, clofibrate
------------------------------------------------------------------

Peroxisome proliferators, such as clofibrate, are known to cause a marked proliferation of peroxisomes in the hepatocytes of animals \[[@B58]-[@B65]\]. Proliferation of peroxisomes is also associated with a predictable pleiotropic response, characterized by hepatomegaly, and the increased steady-state level of mRNAs coding for peroxisomal enzymes \[[@B61]\]. In this study, we first wished to determine if clofibrate acts as a peroxisome proliferator in zebrafish as vertebrate species show different responses to clofibrate as assayed by peroxisome proliferation or induction of steady-state transcript levels for several clofibrate-responsive genes. Rats and mice are more responsive to clofibrate than hamsters and humans \[[@B66],[@B67]\], while some fish, such as medaka and rainbow trout, show little response \[[@B51]\], and sea bass is essentially refractory to clofibrate treatment \[[@B68]\]. The number of peroxisomes was higher in hepatocytes of zebrafish fed ≥ 0.75% clofibrate (Figure [1](#F1){ref-type="fig"}B) compared to livers of zebrafish not fed clofibrate (Figure [1](#F1){ref-type="fig"}A). The number of peroxisomes in liver increased 4-fold in zebrafish fed ≥ 0.75% clofibrate compared to the control (Figure [1](#F1){ref-type="fig"}C). The peroxisomal numbers in intestine did not change with clofibrate treatment, whereas, in other tissues like muscle, brain and heart, we could not observe any peroxisomes (data not shown). Previous studies in rats and mice fed clofibrate showed an increase in the number of mitochondria in the liver \[[@B69]-[@B71]\]. In this study, zebrafish fed ≥ 0.75% clofibrate showed an increase in the number of mitochondria only in heart cells (Figure [2](#F2){ref-type="fig"}B) compared to the control (Figure [2](#F2){ref-type="fig"}A). The number of mitochondria in heart cells increased 2-fold in zebrafish fed ≥ 0.75% clofibrate compared to the control (Figure [2](#F2){ref-type="fig"}C). The mitochondrial number in other tissues (liver, intestine, muscle and brain) examined did not change in zebrafish fed clofibrate.

![**Electron micrographs of hepatocytes of zebrafish after clofibrate treatment.** Staining of peroxisomes in the hepatocytes of zebrafish fed 0% clofibrate **(A)** and 1.00% clofibrate **(B)**. Number of peroxisome per field of view in liver increased with increasing concentration of clofibrate fed zebrafish **(C)**. Arrows point to peroxisomes. Bar = 2 μm.](1471-2148-12-112-1){#F1}

![**Electron micrographs of heart cells of zebrafish after clofibrate treatment.** Mitochondria in the heart cells of zebrafish fed 0% clofibrate **(A)** and 1.00% clofibrate **(B)**. Number of mitochondria per field of view in heart increased with increasing concentration of clofibrate fed zebrafish **(C)**. Bar = 2 μm.](1471-2148-12-112-2){#F2}

Clofibrate has been widely used in vertebrates to activate PPARα, and in some instances PPARγ, to induce transcriptional initiation of genes involved in lipid homeostasis, such as the acyl-CoA oxidase 1 (*Acox1*) gene, a gene that contains a peroxisome proliferator response element (PPRE) \[[@B52],[@B65],[@B72],[@B73]\]. In rats, transcriptional initiation of PPARα-responsive genes are up-regulated in the liver, moderately up-regulated in the small intestine and to a lesser extent up-regulated in other tissues, such as skeletal muscle, heart and kidney by clofibrate \[[@B56]\]. The level of *Acox1* mRNA in liver, heart, kidney, duodenum and jejunum is increased in rats fed clofibrate compared to controls, but not in ileum and brain \[[@B56]\]. Clofibrate was also shown to increase the level of *Acox1* mRNA in liver of chicken \[[@B54]\], liver and adipose tissue of pigs \[[@B55]\], hepatocytes of rainbow trout \[[@B63]\] and liver of rats \[[@B64]\]. In this study, the steady-state level of *acox1* mRNA increased 3-fold in liver (Figure [3](#F3){ref-type="fig"}A), 3-fold in intestine (Figure [3](#F3){ref-type="fig"}B), 2-fold in muscle (Figure [3](#F3){ref-type="fig"}C) and 2.5-fold in heart (Figure [3](#F3){ref-type="fig"}D) of zebrafish fed ≥ 0.50% clofibrate compared to zebrafish fed \< 0.50% clofibrate.

![**The steady-state level of *acox1* mRNA and hnRNA in various tissues of zebrafish fed clofibrate.** The level of mRNA and hnRNA of the *acox1* gene in liver **(A, F)**, intestine **(B, G)**, muscle **(C, H)**, heart **(D, I)** and brain **(E, J)** was determined by RT-qPCR using gene-specific primers. The steady-state level of *acox1* transcripts was normalized to the steady-state level of *rpl13α* transcripts in the same sample. Data are presented as the mean ratio ± S.E.M. Significant differences (*p* \< 0.05) in the relative steady-state level of *acox1* mRNA and hnRNA between zebrafish \[n = 12, (male = 6, female = 6)\] fed different concentrations of clofibrate compared to zebrafish not fed clofibrate are indicated by an asterisk.](1471-2148-12-112-3){#F3}

To determine if the increased levels of *acox1* mRNA transcripts by clofibrate in various tissues was due to an increased rate of transcriptional initiation, we assayed the steady-state level of hnRNA coded by the *acox1* gene. The level of hnRNA for a given gene is an indirect estimate of the rate of transcriptional initiation for that gene as the processing of hnRNA to mRNA occurs rapidly \[[@B74]\]. Zebrafish *acox1* hnRNA increased 2.5-fold in liver (Figure [3](#F3){ref-type="fig"}F), 2-fold in intestine (Figure [3](#F3){ref-type="fig"}G), 8-fold in muscle (Figure [3](#F3){ref-type="fig"}H) and 4-fold in heart (Figure [3](#F3){ref-type="fig"}I) of fish fed ≥ 0.50% clofibrate compared to zebrafish fed \< 0.50% clofibrate indicating an increase of transcriptional initiation of the *acox1* gene in these tissues. In brain, *acox1* mRNA and hnRNA levels did not change in zebrafish fed clofibrate (Figure [3](#F3){ref-type="fig"}E[3](#F3){ref-type="fig"}J). The lack of affect on the level of *acox1* transcripts in the brain of zebrafish fed clofibrate may be due to: (i) clofibrate does not cross the blood brain barrier, or (ii) if clofibrate does cross the blood brain barrier, the *acox1* gene is not induced by clofibrate in the brain of zebrafish. The increased number of peroxisomes and mitochondria in the liver and heart, respectively, and the induction of the transcriptional initiation of the *acox1* gene by clofibrate in liver, intestine, muscle and heart is compelling evidence that zebrafish is responsive to this peroxisome proliferator, like many other vertebrates \[[@B58]-[@B72],[@B75]\].

Tissue-specific up-regulation of zebrafish *fabp* transcription by clofibrate
-----------------------------------------------------------------------------

Some mammalian *FABP* genes are induced by various FAs and peroxisome proliferators, and molecular mechanisms for their induction have been proposed \[[@B46],[@B76]-[@B80]\]. FABPs transport long-chain FAs from the cytoplasm to the nucleus \[[@B80],[@B81]\]. Inside the nucleus, FABPs transfer their long-chain FAs to nuclear receptors, such as PPARα and PPARγ \[[@B82]-[@B84]\]. Dietary long chain FAs and peroxisome proliferators activate these nuclear receptors, and once activated, these nuclear receptors form heterodimers with retinoic-acid receptors (RAR) or retinoid X receptors (RXR) (*e.g.,* PPAR-RAR and PPAR-RXR), which in turn bind to response elements in *FABP* genes, and thereby, stimulate initiation of transcription \[[@B85]-[@B91]\]. Previous reports have shown that FAs and peroxisome proliferators increase the steady-state level of *L-FABP* (*FABP1*) and *I-FABP* (*FABP2*) gene transcripts in the mammalian liver and small intestine \[[@B43],[@B76],[@B77],[@B79],[@B92],[@B93]\]. Peroxisome proliferators also increase the transcriptional activity of *A-FABP* (*FABP4*) in adipocytes of mice \[[@B46],[@B84]\].

Up-regulation of transcription of duplicated zebrafish *fabp1* genes by clofibrate
----------------------------------------------------------------------------------

In this study, the steady-state level of *fabp1a* mRNA increased 1.5-fold in the intestine of zebrafish fed 0.50% and 0.75% clofibrate (Figure [4](#F4){ref-type="fig"}A) and increased 4-fold in muscle of zebrafish fed 0.50% clofibrate compared to zebrafish not fed clofibrate (Figure [4](#F4){ref-type="fig"}E). In heart cells of zebrafish fed ≥ 0.75% clofibrate, *fabp1b.1* mRNA increased 2-fold compared to zebrafish not fed clofibrate (Figure [4](#F4){ref-type="fig"}J). To determine if the increased levels of *fabp1a* mRNAs was the result of transcriptional initiation, we assayed the levels of hnRNA for these *fabp* genes in various tissues of zebrafish. The steady-state level of *fabp1a* hnRNA increased 6-fold in intestine of zebrafish fed ≥ 0.50% clofibrate (Figure [4](#F4){ref-type="fig"}D) and \> 5-fold in muscle of zebrafish fed 0.50% clofibrate (Figure [4](#F4){ref-type="fig"}H). In zebrafish fed ≥ 0.50% clofibrate, the level of *fabp1b.1* hnRNA in heart increased 3-fold compared to zebrafish fed the control diet. (Figure [4](#F4){ref-type="fig"}L). The levels of *fabp1a* mRNA in heart (Figure [4](#F4){ref-type="fig"}I), *fabp1b.1* mRNA in intestine (Figure [4](#F4){ref-type="fig"}B), *fabp1b.1* mRNA in muscle (Figure [4](#F4){ref-type="fig"}F), *fabp1b.2* mRNA in intestine (Figure [4](#F4){ref-type="fig"}C), *fabp1b.2* mRNA in muscle (Figure [4](#F4){ref-type="fig"}G) and *fabp1b.2* mRNA in heart (Figure [4](#F4){ref-type="fig"}K) remained unchanged in zebrafish fed clofibrate.

![**The steady-state level of *fabp1a/fabp1b.1/fabp1b.2* mRNA and hnRNA in intestine (A, B, C, D), muscle (E, F, G, H) and heart (I, J, K, L) of zebrafish fed clofibrate.** The level of mRNA and hnRNA was determined by RT-qPCR using gene-specific primers. The steady-state level of *fabp* transcripts was normalized to the steady-state level of *rpl13α* transcripts in the same sample. Data are presented as the mean ratio ± S.E.M. Significant differences (*p* \< 0.05) in the relative steady-state level of *fabp* mRNAs between zebrafish \[n = 12, (male = 6, female = 6)\] fed different concentrations of clofibrate compared to zebrafish not fed clofibrate are indicated by an asterisk.](1471-2148-12-112-4){#F4}

Up-regulation of transcription of zebrafish *fabp7* genes by clofibrate
-----------------------------------------------------------------------

Duplicated copies of zebrafish *fabp7* (*fabp7a* and *fabp7b*) exhibited distinct tissue-specific patterns of up-regulation by clofibrate of levels of both mRNA and hnRNA (Figure [5](#F5){ref-type="fig"}). *fabp7a* mRNA increased \> 7-fold in liver of zebrafish fed 0.50% clofibrate (Figure [5](#F5){ref-type="fig"}A) and \> 2-fold in intestine of zebrafish fed 1.00% clofibrate (Figure [5](#F5){ref-type="fig"}D), while *fabp7b* mRNA levels increased 6-fold only in muscle of zebrafish fed ≥ 0.50% clofibrate compared to zebrafish not fed clofibrate (Figure [5](#F5){ref-type="fig"}H).

![**The steady-state level of *fabp7a/fabp7b* mRNA and hnRNA in liver (A, B, C), intestine (D, E, F) and muscle (G, H, I) of zebrafish fed clofibrate.** The level of mRNA and hnRNA was determined by RT-qPCR using gene-specific primers. The steady-state level of *fabp* transcripts was normalized to the steady-state level of *rpl13α* transcripts in the same sample. Data are presented as the mean ratio ± S.E.M. Significant differences (*p* \< 0.05) in the relative steady-state level of *fabp* mRNAs between zebrafish \[n = 12, (male = 6, female = 6)\] fed different concentrations of clofibrate compared to zebrafish not fed clofibrate are indicated by an asterisk.](1471-2148-12-112-5){#F5}

The increase in the mRNA levels of zebrafish *fabp7* genes correlated with the increase in the levels of their hnRNA. *fabp7a* hnRNA increased \> 3-fold in liver of zebrafish fed 0.50% clofibrate (Figure [5](#F5){ref-type="fig"}C) and 7-fold in intestine of zebrafish fed ≥ 0.75% clofibrate (Figure [5](#F5){ref-type="fig"}F), while *fabp7b* hnRNA increased 6-fold in muscle of zebrafish fed ≥ 0.50% clofibrate (Figure [5](#F5){ref-type="fig"}I) compared to control zebrafish. No change was observed in the levels of *fabp7b* mRNA transcripts in liver (Figure [5](#F5){ref-type="fig"}B) and intestine (Figure [5](#F5){ref-type="fig"}E), and *fabp7a* mRNA in muscle (Figure [5](#F5){ref-type="fig"}G) in zebrafish fed clofibrate.

Up-regulation of zebrafish *fabp10* gene transcription by clofibrate
--------------------------------------------------------------------

The steady-state level of *fabp10a* mRNA increased \> 2-fold in liver of zebrafish fed 0.50% clofibrate compared to control (Figure [6](#F6){ref-type="fig"}A), whereas the level of *fabp10b* mRNA (Figure [6](#F6){ref-type="fig"}B) did not change in the liver of zebrafish fed clofibrate. A 3-fold increase of *fabp10a* hnRNA mirrored the increase of mRNA coded by this gene in liver of zebrafish fed 1.00% clofibrate compared to control zebrafish (Figure [6](#F6){ref-type="fig"}C).

![**The steady-state level of *fabp10a/fabp10b* mRNA and hnRNA in liver (A, B, C) and *fabp11a/fabp11b* (mRNA and hnRNA) in liver (D, E, F) of zebrafish fed clofibrate.** The level of mRNA and hnRNA was determined by RT-qPCR using gene-specific primers. The steady-state level of *fabp* transcripts was normalized to the steady-state level of *rpl13α* transcripts in the same sample. Data are presented as the mean ratio ± S.E.M. Significant differences (*p* \< 0.05) in the relative steady-state level of *fabp* mRNAs between zebrafish \[n = 12, (male = 6, female = 6)\] fed different concentrations of clofibrate compared to zebrafish not fed clofibrate are indicated by an asterisk.](1471-2148-12-112-6){#F6}

Up-regulation of zebrafish *fabp11* gene transcription by clofibrate
--------------------------------------------------------------------

The steady-state level of *fabp11a* mRNA (Figure [6](#F6){ref-type="fig"}D) increased 3-fold in liver of zebrafish fed ≥ 0.75% clofibrate compared to control, but the steady-state level of *fabp11b* transcripts (Figure [6](#F6){ref-type="fig"}E) did not change in the liver of zebrafish fed clofibrate. Similarly, *fabp11a* hnRNA increased \> 4-fold in liver of zebrafish fed ≥ 0.75% clofibrate compared to control (Figure [6](#F6){ref-type="fig"}F). No difference in the steady-state level of any *fabp* mRNA and hnRNA assayed was observed between male and female zebrafish (data not shown).

Conclusion
==========

We report here that zebrafish fed clofibrate exhibited distinct patterns of up-regulation of the steady-state level of mRNAs of duplicated *fabp* genes (Table[1](#T1){ref-type="table"}). None of the levels of *fabp* mRNA transcripts assayed changed in the brain of zebrafish fed clofibrate (data not shown). Furthermore, changes in the levels of mRNA for a specific *fabp* gene were directly correlated with changes in the steady-state level of hnRNA for that particular *fabp* gene indicating that clofibrate induced transcriptional initiation of zebrafish *fabp* genes (Table[1](#T1){ref-type="table"}). Clofibrate induction of some zebrafish *fabp* genes appears, however, to be controlled by a tissue-specific mechanism(s), as induction of the steady-state level of *fabp* mRNAs and hnRNAs by clofibrate was seen for both duplicated copies of *fabp1a/fabp1b.1,* and *fabp7a/fabp7b*, but in different tissues. Clofibrate also increased the steady-state level of *fabp10a* and *fabp11a* mRNAs and hnRNAs in liver*,* but not for *fabp10b* and *fabp11b*.

###### 

**Steady-state levels of specific mRNA and hnRNA of *fabp* genes increased in tissues of zebrafish after clofibrate treatment**

  **Gene**     **Liver**     **Intestine**   **Muscle**   **Heart**   **Brain**
  ------------ ------------- --------------- ------------ ----------- -----------
  *acox1*      ~**+**~       ~**+**~         ~**+**~      ~**+**~     **-**
  *fabp1a*     ~** *−* **~   ~**+**~         ~**+**~      ~**−**~     **-**
  *fabp1b.1*   ~** *−* **~   **-**           **-**        ~**+**~     **-**
  *fabp1b.2*   ~** *−* **~   **-**           **-**        ~**−**~     **-**
  *fabp7a*     ~**+**~       **+**           **-**        ~**−**~     **-**
  *fabp7b*     ~** *−* **~   **-**           ~**+**~      ~**−**~     **-**
  *fabp10a*    ~**+**~       **-**           **-**        ~**−**~     **-**
  *fabp10b*    ~** *−* **~   **-**           **-**        ~**−**~     **-**
  *fabp11a*    ~**+**~       **-**           **-**        ~**−**~     **-**
  *fabp11b*    ~** *−* **~   **-**           **-**        ~**−**~     **-**

+, increase relative to control.

-, no change relative to control.

Based on *in silico* analyses, we found that most zebrafish *fabp* genes contain putative PPREs within 7 kilobase pairs (kb) of DNA upstream of the transcriptional initiation site of each *fabp* gene (data not shown). Since functional PPREs that activate gene transcription *via* peroxisome proliferators have also been found in introns \[[@B73],[@B94]\], we screened the intronic sequences of each of the zebrafish *fabp* genes described in this paper for PPREs. Many of these *fabp* genes contained putative PPREs in their introns (data not shown). While *in silico* analyses can be very useful in determining the direction of future experimental work, the results of *in silico* analyses must be interpreted cautiously. To illustrate this cautionary point, *in silico* analysis of the rat peroxisomal thiolase B gene identified a putative PPRE in the promoter region of this gene that did not bind PPARα *in vitro*, but subsequent studies showed that a functional PPRE in intron 3 of this gene did bind an activated PPARα *in vitro*\[[@B94]\]. To demonstrate that the putative PPREs we have found by *in silico* analysis in the various zebrafish *fabp* genes are indeed functional will require studies involving deletion of PPREs and/or site directed mutation of putative PPRE sequences in the *fabp* promoters and introns to demonstrate loss of function in various cell culture lines and transgenic zebrafish. If functional PPREs are identified in the zebrafish *fabp* genes, the most parsimonious explanation of the tissue-specific differential induction of transcriptional initiation of the duplicated zebrafish *fabp1a/fabp1b.1* and *fabp7a/fabp7b* genes by clofibrate is that both duplicated copies of these gene have retained a functional PPRE, but that induction by clofibrate is over-ridden by an, as yet, unknown tissue-specific mechanism(s). An alternative explanation is that induction of *fabp* transcriptional initiation by clofibrate is mediated *via* an indirect mechanism wherein the induction of *fabp* genes occurs by an intermediate or "upstream" gene activated by PPAR coding for a transcription factor, which in turn activates zebrafish *fabp* genes. Again, however, this indirect induction of *fabp* gene transcription by clofibrate-activated PPAR must be mediated by an over-riding tissue-specific mechanism(s). Whether clofibrate-induced transcription of zebrafish *fabp* genes is the result of clofibrate-activated PPAR directly at a *fabp* PPRE or indirectly *via* an "upstream" gene coding for a regulatory protein, the regulatory DNA elements in the duplicated *fabp* genes have certainly diverged markedly since the WGD event \~230-400 million years ago \[[@B4],[@B13]-[@B17]\], thereby supporting the DDC model \[[@B6],[@B7]\] for the retention of these duplicated *fabp* genes in the zebrafish genome.

Materials and methods
=====================

Experimental diet and zebrafish husbandry
-----------------------------------------

Experimental diets containing five different concentrations (0, 0.25, 0.50, 0.75 and 1.00% w/w) of clofibrate (Sigma-Aldrich, Oakville, Ontario, Canada) were formulated (Table[2](#T2){ref-type="table"}). Clofibrate concentrations and basic feed formulation were based on previous dietary studies \[[@B57],[@B95]-[@B97]\] and the United States National Research Council's nutrient requirement recommendations for warm-water fishes \[[@B95]\]. The dry ingredients were mixed using a Hobart mixer for 20 min. Choline chloride was dissolved in distilled water and clofibrate mixed in corn oil prior to addition to dry ingredients. Boiling water was added to the dry ingredients to make wet dough (40% v/v). The dough was spread on tray and freeze-dried for 36--48 h. The freeze-dried diet was then passed through a 0.8 mm mesh to yield particles of less than 800 μm, which were then stored at −20°C.

###### 

Composition of diets (% by weight)

  **Ingredients**          **0% clofibrate diet**   **0.25% clofibrate diet**   **0.50% clofibrate diet**   **0.75% clofibrate diet**   **1.00% clofibrate diet**
  ------------------------ ------------------------ --------------------------- --------------------------- --------------------------- ---------------------------
  Vitamin free casein^a^   33                       33                          33                          33                          33
  Wheat gluten^b^          10                       10                          10                          10                          10
  Gelatin^a^               4                        4                           4                           4                           4
  Corn oil^c^              4                        4                           4                           4                           4
  Fish oil^d^              4                        4                           4                           4                           4
  Corn starch^e^           33                       33                          33                          33                          33
  Celufil^1^               8.00                     7.75                        7.50                        7.25                        7.00
  Vitamin mix^f^           1.30                     1.30                        1.30                        1.30                        1.30
  Mineral mix^g^           1                        1                           1                           1                           1
  Betaine^h^               1.50                     1.50                        1.50                        1.50                        1.50
  DL-Methionine^a^         0.20                     0.20                        0.20                        0.20                        0.20
  Clofibrate^i^            0                        0.25                        0.50                        0.75                        1.00
  Total                    100                      100                         100                         100                         100

^a^ US Biochemical. (Cleveland, OH, USA).

^b^ Dover Mills Ltd. (Halifax, NS, Canada).

^c^ Sobeys Inc. (Halifax, NS, Canada).

^d^ Corey Feeds Ltd. (Fredericton, NB, Canada).

^e^ National Starch and Chemical Co. (Bridgewater, NJ, USA).

^f^ Vitamin added to supply the following (per kg diet): vitamin A, 8000 IU; vitamin D3, 4000 IU; vitamin E, 300 IU; menadione sodium bisulfite, 40 mg; Thiamine HCl, 50 mg; riboflavin, 70 mg; d-Ca pantothenate, 200 mg; biotin, 1.5 mg; folic acid, 20 mg; vitamin B12, 0.15 mg; niacin, 300 mg; pyridoxine HCl, 20 mg; ascorbic acid, 300 mg; inositol, 400 mg; choline chloride, 2000 mg; butylated hydroxy toluene, 15 mg; butylated hydroxy anisole, 15 mg.

^g^ Mineral added to supply the following (per kg diet): manganous sulphate (32.5% Mn), 40 mg; ferrous sulphate (20.1% Fe), 30 mg; copper sulphate (25.4% Cu), 5 mg; zinc sulphate (22.7% Zn), 75 mg; sodium selenite (45.6% Se), 1 mg; cobalt chloride (24.8% Co), 2.5 mg; sodiumfluoride (42.5% F), 4 mg.

^h^ Betaine anhydrous (96% feed grade). (Finnfeeds, Finland). ^i^ Sigma-Aldrich Inc. (St. Louis, MO, USA).

To reduce genetic variance, four female and two male adult zebrafish of the AB strain \[[@B98]\], obtained from the Aquatron at Dalhousie University, were bred in a single tank to produce embryos. Embryos, larvae and adult fish were maintained in aerated water at 28.5°C on a 14 h light and 10 h dark cycle \[[@B99]\]. One hundred and fifty day-old zebrafish were acclimatized in 35 L aquaria for four weeks prior to feeding fish diets containing clofibrate. Three replicates of five different dietary groups of fish were distributed in 15 tanks in a randomized complete block design. Each tank contained 15 zebrafish. Fish in each tank were maintained under the same light intensity and photoperiod. After acclimatization for a week, fish were fed the experimental diets twice a day to satiation. At the end of four weeks, fish were anaesthetized by immersion in a solution of 0.20% (v/v) MS-222 prior to tissue dissection. Dissection of fish was done on ice. From each fish, liver, intestine, muscle, brain and heart were removed. All experimental protocols were approved by the Dalhousie University Committee on Laboratory Animals in accordance with the recommendations of the Canadian Council on Animal Care.

Electron microscopy to visualize peroxisomes and mitochondria
-------------------------------------------------------------

Tissue samples (liver, intestine, muscle, brain and heart) from 0, 0.25, 0.50, 0.75 and 1.00% (w/w) clofibrate-fed fish were dissected and transferred to centrifuge tubes containing 2% glutraldehyde fixative (osmolarity \~300 mOsm) for 30--40 min on ice \[[@B100]\]. The tissue samples were subjected to three 10-minute washes in 0.1 M cacodylate buffer. The samples were transferred to 0.1 M Tris--HCl buffer and washed twice for 10 min. The samples were pre-incubated in 1% diaminobenzidine (DAB) solution for 30 min at 37°C with shaking. Ten μl of 30% hydrogen peroxide solution was added and the samples were incubated for 20--30 min at 37°C with shaking. Tissues were washed in 0.1 M TBS for 10 min and transferred to centrifuge tubes and subjected to three 10-minute washes with 0.1 M cacodylate buffer at room temperature \[[@B101]\]. Finally, the tissues were post-fixed in 1% osmium in 0.1 M cacodylate buffer for 1 h at 4°C and washed in filtered, deionized H~2~O for 15 min. Tissues were dehydrated for transmission electron microscopy, infiltrated overnight and later embedded in epon resin \[[@B102]\]. Ten electron microscopy images of tissues for peroxisomes and mitochondria were counted in tissues of adult zebrafish fed different concentrations of clofibrate.

RNA isolation, cDNA synthesis and RT-qPCR
-----------------------------------------

Total RNA was extracted from adult zebrafish tissues using TRIzol (Invitrogen, Carlsbad, CA, USA) according to the protocol recommended by the supplier. The quality and quantity of extracted RNA was assessed by agarose gel-electrophoresis and spectrophotometry at 260 nm, respectively. cDNA was synthesized from mRNA using an oligo (dT) primer according to the manufacturer's protocol for the omniscript RT kit (Qiagen, Mississauga, Canada). cDNA was synthesized from hnRNA using random hexamers. Primer sequences for the quantification of mRNA and hnRNA encoded by different *fabp* genes and their annealing temperature (AT) for primer pairs of each *fabp* gene during PCR are shown in Table[3](#T3){ref-type="table"}. To assay specific hnRNAs, one primer was complementary to an intronic sequence, while the other was complementary to an exonic sequence. *acox1*, a gene known to be induced by clofibrate in many organisms \[[@B52],[@B72]\] was used as a positive control.

###### 

Primer sequences used for RT-qPCR

  **Gene symbol**        **Entrez Gene ID**   **Forward primer 5\' -› 3\'**   **Reverse primer 5\' -› 3\'**   **AT**^**a**^
  ---------------------- -------------------- ------------------------------- ------------------------------- ---------------
  mRNA quantification                                                                                         
  *fabp1a*               791610               TAAGCTGACAGCGTTTGTGAAGGG        AGATGCGTCTGCTGATCCTCTTGT        60.0
  *fabp1b.1*             554095               AAGCTGAAGGTGGTGCTGAACA          CACGTTTGCTGATGCGCTTGTA          59.0
  *fabp1b.2*             EB880179             TGCCGTTCTCTGGGAAGTTTGAGT        TGACTTTGTCTCCGCTCAGCATCT        61.0
  *fabp7a*               58128                TGTGCCACTTGGAAACTGGTTGAC        AACATTGCCTACTTGCCTGGTAGG        60.0
  *fabp7b*               407736               AAACCACTGCTGATGACCGACACT        AGTGGTCTCTTTCCCATCCCACTT        61.0
  *fabp10a*              171481               TTACGCTCAGGAGAACTACG            CTTCCTGATCATGGTGGTTC            55.0
  *fabp10b*              795210               CGGCTCCAGAGCACTACATC            GTTCACTCATGTGCGGGAGC            60.0
  *fabp11a*              447944               TGTGCAGAAACAGACCTGGGA           ACAGCCACCACATCACCCATCTT         60.0
  *fabp11b*              553579               GCTGTCACTACATTCAAGACCTG         AGTTTACCATCCGCAAGGCTCA          60.0
  *acox1*                449662               AGTCAGCACGAGCTCTCTCC            GCCCTACAAAGTGAAAGGCA            58.0
  *rpl13α*               560828               AGCAAGTGCTGTTGGGCCAC            GTGTGGCGGTGATGGCCTGG            61.0
  hnRNA quantification                                                                                        
  *fabp1a*               791610               ATCAATGGAGGTCAACGGCGAC          CAGCATGCGTGAAGCCGCCC            62.5
  *fabp1b.1*             554095               GAACTAACGTGTGCTGCTTGTG          CACGTTTGCTGATGCGCTTGTA          57.0
  *fabp7a*               58128                CCATCCATCAGATTTCTATGTGGG        CATTATGCCTTCTCGTATGTGCG         56.5
  *fabp7b*               407736               TTGGAAATGTGACCAAACCGACGC        TCGTCTCGAAAGGGAATGCAGTGT        61.5
  *fabp10a*              171481               TCCAGCAGAACGGCAGCGAC            CGCCTGTAAAGTGAAGCCATTTCCA       61.0
  *fabp11a*              447944               CCAAGCCGTTTTTGATGATGTGAG        GCTATTAATTTCCCATCCGACACC        57.0
  *acox1*                449662               GGCTACTCCCGCTGCAGCAG            GGCCTGAGGGTTGTTGGGCC            63.0
  *rpl13α*               560828               ACCAACCCTTCCCGTGGACCA           AGCCAATGCTTGCTTCTACAACAGA       61.5

^a^AT, annealing temperature (°C).

Amplification of cDNA samples and DNA standards was carried out using the QuantiTect SYBR Green PCR Kit (Qiagen, Mississauga, Ontario, Canada) following the manufacturer\'s instructions. For thermal cycling and fluorescence detection, a Rotor-Gene 3000 system (Corbett Research, Sydney, Australia) was used. PCR conditions were: initial hold for 15 min at 95°C followed by 40 cycles of 15 s denaturation at 94°C, 20 s annealing of primers at different temperatures depending on the primer pairs (see Table[3](#T3){ref-type="table"}), and 30 s of elongation at 72°C. Following completion of the PCR cycles, the melting temperature of the PCR product was determined as an indication that total fluorescence was derived from a single gene-specific product. Fluorescence was measured following each cycle. The copy number of mRNA and hnRNA for each *fabp* gene was determined using the standard curves as explained by Bustin *et al.*\[[@B103]\]. As negative controls, reverse transcriptase was omitted from cDNA synthesis reactions for each sample and these controls were subjected to quantitative PCR. To determine the relative steady-state level of *fabp* mRNA and hnRNA transcripts in each tissue, the absolute copy number of *fabp* mRNA and hnRNA transcripts was divided by the copy number of ribosomal protein large subunit 13α (*rpl13α*) \[[@B104]\] mRNA and hnRNA transcripts in each sample.

Statistical analysis
--------------------

Statistical analyses were performed using the GraphPad PRISM® software version-5 (San Diego, California, USA). Data were analyzed using one-way analysis of variance (ANOVA). *Post hoc* comparisons were conducted using the Tukey's Multiple Comparison Test. The level of significance was chosen at *p* \< 0.05 and the results were presented as means ± S.E.M.
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DDC: Duplication-degeneration-complementation; WGD: Whole genome duplication; FAs: Fatty acids; hnRNA: Heterogenous nuclear RNA; FABP: Mammal fatty acid-binding protein; FABP: Mammal fatty acid-binding protein gene; Fabp: Fish fatty acid-binding protein; Fabp: Fish fatty acid-binding protein gene; PPAR: Peroxisome proliferator-activated receptor; PPRE: Peroxisome proliferator response element; RT-qPCR: Reverse transcription-quantitative polymerase chain reaction.
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